Related Experiment Video
Updated: Jun 23, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Correlation of serum S100B concentration with hospital stay in patients undergoing CABG
Ljuba Krnjak1, Primoz Trunk, Borut Gersak
1Clinical Institute of Clinical Chemistry and Clinical Biochemistry, University Medical Center, Ljubljana, Slovenia. ljuba.krnjak@kclj.si
Insights
Serum S100B protein levels on postoperative days 1 and 5 correlate with hospital stay length in coronary artery bypass grafting patients. This suggests S100B may predict outcomes even without evident cerebral injury.
Area of Science:
- Biochemistry
- Neurology
- Cardiovascular Surgery
Background:
- S100B protein is a potential serum marker for cerebral injury following cardiac surgery.
- Assessing predictive markers for patient outcomes after coronary artery bypass grafting (CABG) is crucial.
Purpose of the Study:
- To investigate the correlation between serum S100B protein concentration and hospital stay duration in CABG patients.
- To determine if elevated S100B levels post-surgery predict longer hospitalizations, even in the absence of clinical neurological deficits.
Main Methods:
- Serum S100B levels were measured preoperatively, immediately post-operation, and on postoperative days 1 and 5 in 32 CABG patients.
- Multivariate linear regression analysis was employed to assess correlations, controlling for operation type and patient characteristics.
Main Results:
- Median hospital stay was 7 days (range: 5-34 days).
- Serum S100B concentrations were significantly elevated post-operation and on day 1 and day 5 compared to preoperative levels.
- S100B levels on postoperative day 1 (p=0.0296) and day 5 (p=0.0021) independently correlated with length of hospital stay.
Conclusions:
- Postoperative serum S100B concentration on days 1 and 5 may serve as a prognostic indicator for hospital stay duration in CABG patients.
- These findings suggest S100B could predict outcomes even in patients without overt clinical signs of cerebral injury.
- Further validation in larger patient cohorts is recommended to confirm these preliminary results.
Abstract:
S100B protein has been proposed to be a serum marker of cerebral injury in patients undergoing cardiac surgery. The question to be answered in the present study was whether an increase in serum S100B concentration after the surgery correlated with the length of hospital stay in patients undergoing coronary artery bypass grafting. To answer this question we measured serum S100B concentration preoperatively, at the end of the operation, and on day 1 and day 5 of the surgery in 32 patients undergoing coronary artery bypass grafting. The median (min; max) hospital stay was 7 days (5; 34), and serum S100B concentration was 0.075 mg/L (0.050;0. 095) preoperatively, 0.840 mg/L (0.390; 1.500) immediately after the operation, 0.180 mg/L (0.150;0. 280) on day 1 and 0.100 mg/L (0.080;0. 120) on day 5 of the operation. None of the patients had clinical signs of cerebral injury. Multivariate linear regression analysis indicated serum S100B concentration on day 1 (p = 0.0296) and day 5 (p = 0.0021) of the operation to correlate with the length of hospital stay independently of the type of operation (with or without the use of cardiopulmonary bypass) and patient clinical characteristics. Our data suggest that serum S100B concentration on day 1 and day 5 of the operation may have prognostic value in patients without clinical signs of cerebral injury. However, this pilot study should be extended to a larger group of patients to confirm this observation.
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome III: Diagnostic Studies
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...